Filing Details
- Accession Number:
- 0001493152-24-016062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-26 08:30:35
- Reporting Period:
- 2024-04-25
- Accepted Time:
- 2024-04-26 08:30:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
318306 | Abeona Therapeutics Inc. | ABEO | Pharmaceutical Preparations (2834) | 830221517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1715291 | Walter Joseph Vazzano | 6555 Carnegie Ave, 4Th Floor Cleveland OH 44103 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-25 | 5,608 | $3.14 | 233,868 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.13 to $3.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.